The stock has lost 7.3% while the S&P 500 ... On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

RBC Capital has once again stamped an "Outperform" rating on The Cigna Group, signaling steady analyst confidence. The price ...

Teva Pharmaceutical (TEVA) stock, Amneal Pharma (AMRX) stock receive Buy ratings and Viatris (VTRS) stock receives a Neutral rating at Goldman Sachs. Read more here.

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated ...

The Cigna Group CI, a longstanding global health company, continues to offer a variety of health solutions and insurance ...

Across the recent three months, 4 analysts have shared their insights on Niagen Bioscience NAGE +12.6% + Free Alerts , ...

Citi analysts reiterated a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD) stock and maintained a $125 price target. The ...

A pair of new companies are being launched to tackle high drug costs, the latest sign of employer frustration with the middlemen, known as PBMs, whose job it is to keep down the spending. The cost ...

Martin has a “buy” rating and $145 price target for RDDT stock, which closed at $109.03 on May 29. Another one of the highest-ranked analysts in the WallStreetZen database is Wedbush analyst ...

QuantumScape has logged a -27.6% 52 week change, compared to 11.1% for the S&P 500 QS has an average analyst rating of hold ...